Remove 2028 Remove FDA Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

One Lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% Mild Lotion Recalled Due to an Impurity that May Pose Health Risks, 28 June 2024 Teva Canada Ltd. The deadline to submit feedback for this plan is 25 July 2024. is recalling one lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion in 60 mL bottles.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. PCPC looks forward to working with the FDA and key stakeholders to implement this important legislation.